The £100 million evergreen fund generated a 40% IRR and 5x MOIC on the disposal of its majority stake in financial services firm Beckett Investment Management Group.
The transactions include five private equity investment sales at a 7% discount to December 2025 NAV and an exit through a GP-led continuation vehicle.
The investment values the Israel-headquartered radiography company at around $109 million.
HarbourVest's FTSE 250-listed trust, which has a 29% allocation to secondaries, first announced plans in April to narrow its persistent discount to NAV.
We map the fair value, cost, and acquisition timeline for one of evergreen capital's most invested-in Q2 continuation funds.
We dive into the $6.7 billion SICAV, which targets secondaries and co-investments across private equity.
We dive into the June performance, portfolio composition, and other details of the FTSE 250-listed fund, which targets investments through primaries, secondaries, and co-investments.
At least 80% of net proceeds from the transaction will be directed toward a share buyback program aimed at generating liquidity and NAV accretion.
Schroders Capital UK Innovation LTAF combines direct investments with primary and secondary fund commitments.
The activist investor remains dissatisfied with the listed trust's underperformance, calling for policy changes and a £500 million secondary sale.
